Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication

Medical Clinic I, Rheinisch-Westfalische Technische Hochschule Aachen, Germany.

OBJECTIVES: We sought to define the effects of short-term beta-adrenergic blocking medication on intracoronary flow characteristics, clinical symptoms and angiographic diameter changes in patients with severe myocardial bridging of the left anterior descending coronary artery. BACKGROUND: Controversy exists regarding the pathophysiology, clinical relevance and optimal therapy in symptomatic patients with myocardial bridges because antianginal drugs have not been systematically tested. METHODS: In 15 symptomatic patients with myocardial bridging of the left anterior descending coronary artery, maximal lumen diameter reductions were evaluated by quantitative coronary angiography. There were no angiographic signs of coronary artery disease. Coronary blood flow velocities (using a 0.014-in. [0.035 cm] Doppler guide wire) were measured at rest, during atrial pacing and during intravenous administration of a short-acting beta-blocker (esmolol, 50 to 500 micrograms/kg body weight per min) with continuous atrial pacing. RESULTS: The maximal angiographic systolic lumen diameter reduction within the myocardial bridges was 83 +/- 9% at rest, with a persistent diastolic diameter reduction of 41 +/- 11% (mean +/- SD). Short-term intravenous beta-blocker therapy decreased the diameter reduction during both systole (from 83 +/- 9% to 62 +/- 11%) and diastole (from 41 +/- 11% to 30 +/- 9%, both p < 0.001). The average diastolic peak flow velocity was higher within the myocardial bridges (33 +/- 13 cm/s) than the proximal (26 +/- 13 cm/s) and distal bridges (17 +/- 4 cm/s, both p < 0.001). During tachypacing, average diastolic peak flow velocity increased within the bridged segments to 63 +/- 21 cm/s versus 29 +/- 12 cm/s in the proximal and 20 +/- 4 cm/s in the distal bridges (both p < 0.001). Beta-receptor blockade produced a return to baseline values (average diastolic peak flow velocity within bridge 35 +/- 16 cm/s, p < 0.001). ST segment changes and symptoms were abolished with beta-blocker administration. CONCLUSIONS: In patients with myocardial bridges, administration of short-acting beta-blockers during atrial pacing alleviates anginal symptoms and signs of ischemia. This effect was mediated by a reduction of vascular compression and maximal flow velocities within the bridged coronary artery segment.

This article has been cited by other articles:

				J.-H. Jung, P.-K. Min, C. W. Sung, S.-H. Lee, S. Choi, J. R. Cho, N. Lee, K.-H. Park, M.-K. Kim, W. J. Park, et al. The Effect of Intracoronary Nicorandil on Coronary Myocardial Bridging Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 180 - 184. [Abstract] [PDF]

				Y. Ishikawa, Y. Akasaka, K. Suzuki, M. Fujiwara, T. Ogawa, K. Yamazaki, H. Niino, M. Tanaka, K. Ogata, S. Morinaga, et al. Anatomic Properties of Myocardial Bridge Predisposing to Myocardial Infarction Circulation, August 4, 2009; 120(5): 376 - 383. [Abstract] [Full Text] [PDF]

				C. Basso, G. Thiene, S. Mackey-Bojack, A. C. Frigo, D. Corrado, and B. J. Maron Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death Eur. Heart J., July 1, 2009; 30(13): 1627 - 1634. [Abstract] [Full Text] [PDF]

				M LEYE, G CALCAGNI, F BRUNELLE, D BONNET, D SIDI, and P OU Coronary myocardial bridging in Noonan syndrome: definitive diagnosis with high-resolution CT Br. J. Radiol., January 1, 2009; 82(973): e8 - e10. [Abstract] [Full Text] [PDF]

				D. R. Gold, J. R. Zolli, and A. N. Makaryus Increased Use of {beta}-Agonists Leading to Non-ST-Segment Elevation Myocardial Infarction in a Patient With Hemodynamically Significant Myocardial Bridging Mayo Clin. Proc., August 1, 2008; 83(8): 956 - 960. [Abstract] [Full Text] [PDF]

				H. W. Huang Myocardial Infarction With Distal Embolization Associated With Myocardial Bridging in a Postoperative Patient: A Case Report Angiology, May 1, 2008; 59(2): 251 - 255. [Abstract] [PDF]

				S M Ko and K S Kim Multidetector-row CT coronary angiographic finding of myocardial bridging Br. J. Radiol., September 1, 2007; 80(957): e196 - e200. [Abstract] [Full Text] [PDF]

				A.-R. Zeina, M. Odeh, J. Blinder, U. Rosenschein, and E. Barmeir Myocardial Bridge: Evaluation on MDCT Am. J. Roentgenol., April 1, 2007; 188(4): 1069 - 1073. [Abstract] [Full Text] [PDF]

				E. Konen, O. Goitein, L. Sternik, Y. Eshet, J. Shemesh, and E. Di Segni The Prevalence and Anatomical Patterns of Intramuscular Coronary Arteries: A Coronary Computed Tomography Angiographic Study J. Am. Coll. Cardiol., February 6, 2007; 49(5): 587 - 593. [Abstract] [Full Text] [PDF]

				M. Kantarci, C. Duran, I. Durur, F. Alper, O. Onbas, M. Gulbaran, and A. Okur Detection of Myocardial Bridging with ECG-Gated MDCT and Multiplanar Reconstruction Am. J. Roentgenol., June 1, 2006; 186(6_Supplement_2): S391 - S394. [Abstract] [Full Text] [PDF]

				J. R. Alegria, J. Herrmann, D. R. Holmes Jr, A. Lerman, and C. S. Rihal Myocardial bridging Eur. Heart J., June 2, 2005; 26(12): 1159 - 1168. [Abstract] [Full Text] [PDF]

				Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al. Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362. [Full Text] [PDF]

				A. F. Low, B.-L. Chia, W.-L. Ng, and Y.-T. Lim Bridge Over Troubling Spasm: Is the Association of Myocardial Bridging and Coronary Artery Spasm a Distinct Entity?: Three Case Reports Angiology, March 1, 2004; 55(2): 217 - 220. [Abstract] [PDF]

				J. Escaned, J. Cortes, A. Flores, J. Goicolea, F. Alfonso, R. Hernandez, A. Fernandez-Ortiz, M. Sabate, C. Banuelos, and C. Macaya Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging J. Am. Coll. Cardiol., July 16, 2003; 42(2): 226 - 233. [Abstract] [Full Text] [PDF]

				M J Lovell and C J Knight Invasive assessment of myocardial bridges Heart, July 1, 2003; 89(7): 699 - 700. [Full Text] [PDF]

				M. G. Bourassa, A. Butnaru, J. Lesperance, and J.-C. Tardif Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies J. Am. Coll. Cardiol., February 5, 2003; 41(3): 351 - 359. [Abstract] [Full Text] [PDF]

				S. Mohlenkamp, W. Hort, J. Ge, and R. Erbel Update on Myocardial Bridging Circulation, November 12, 2002; 106(20): 2616 - 2622. [Full Text] [PDF]

				P. Angelini, J. A. Velasco, and S. Flamm Coronary Anomalies: Incidence, Pathophysiology, and Clinical Relevance Circulation, May 21, 2002; 105(20): 2449 - 2454. [Full Text] [PDF]

				S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]

				P K Haager, E R Schwarz, J v. Dahl, H G Klues, T Reffelmann, and P Hanrath Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging Heart, October 1, 2000; 84(4): 403 - 408. [Abstract] [Full Text]

				B D Prendergast, F Kerr, and I R Starkey Normalisation of abnormal coronary fractional flow reserve associated with myocardial bridging using an intracoronary stent Heart, June 1, 2000; 83(6): 705 - 707. [Abstract] [Full Text]

				A. Dodge-Khatami, C. Mavroudis, and C. L. Backer Congenital Heart Surgery Nomenclature and Database Project: anomalies of the coronary arteries Ann. Thorac. Surg., April 1, 2000; 69(4): S270 - 297. [Abstract] [Full Text] [PDF]

				V. Sanchez and J. Zamorano New approach to the diagnosis of myocardial bridging by intracoronary ultrasound and Doppler Eur. Heart J., December 1, 1999; 20(23): 1687 - 1688. [PDF]

				J Ge, A Jeremias, A Rupp, M Abels, D Baumgart, F Liu, M Haude, G Gorge, C Von Birgelen, S Sack, et al. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler Eur. Heart J., December 1, 1999; 20(23): 1707 - 1716. [Abstract] [PDF]

				G. Roul, P. Sens, P. Germain, and P. Bareiss Myocardial Bridging as a Cause of Acute Transient Left Heart Dysfunction Chest, August 1, 1999; 116(2): 574 - 580. [Abstract] [Full Text] [PDF]

				S. H. Elson, W. J. Lauer, and T. A. Carlson Myocardial Bridging • Response Circulation, June 29, 1999; 99 (25): 3323 - 3326. [Full Text] [PDF]

				A. T. Yetman, B. W. McCrindle, C. MacDonald, R. M. Freedom, and R. Gow Myocardial Bridging in Children with Hypertrophic Cardiomyopathy -- A Risk Factor for Sudden Death N. Engl. J. Med., October 22, 1998; 339(17): 1201 - 1209. [Abstract] [Full Text] [PDF]

				H. G. Klues, E. R. Schwarz, J. vom Dahl, T. Reffelmann, H. Reul, K. Potthast, C. Schmitz, J. Minartz, W. Krebs, and i. Hanrath Disturbed Intracoronary Hemodynamics in Myocardial Bridging : Early Normalization by Intracoronary Stent Placement Circulation, November 4, 1997; 96(9): 2905 - 2913. [Abstract] [Full Text]